Pharma Companies Offering Franchise Opportunity in india
Nexkem pharma is into providing of our multi-dimensional range of pharmaceutical products. Devoted and submitted experts, who can work for the welfare of PCD Pharma […]
Pharma
Are there any pharma companies that offer 100% tuition reimbursement if one pursues part-time school while working?
Follow-up question: – Any pharmas that encourage joint working-PhD programs that aren’t insanely competitive/impossible to get into? I currently work at Pfizer, they offer $10k […]
Know About 513(g) Exempt Devices
In the clinical administrations, clinical gadgets are ordered in three distinct sorts of class I, class II, and Type III once in a while. Amongst […]
Why do Medicines have crazy names?
submitted by /u/VenistroBiotech [link] [comments]
If you want to learn more about pharmacology and pills..
Check out these subs. There’s a lot to learn from r/pharmaceuticalbenzos and r/pillporn Thanks submitted by /u/AvailableToTalk [link] [comments]
Bayer Agrees To Buy Personalized Vitamin Company Care/of At $225 Million Valuation
Pharmaceutical company Bayer AG has agreed to buy a majority stake in online personalized vitamin and supplement startup Care/of, Bayer confirmed to Bloomberg. submitted by […]
Value of Research
Hello guys I just want to know what are your insights and opinion about the Value of Research and development in this time of pandemic […]
GoodRx files to go public
GoodRx, a digital health startup that helps users track prescription drug prices, filed for an IPO on Friday. The company hasn’t yet priced its shares, but […]
Bayer Reports the NDA Submission to NMPA for Vericiguat to Treat Chronic Heart Failure in China
Shots: The NDA submission was submitted to NMPA’s CDE and is based on P-III VICTORIA study, seeking regulatory approval of vericiguat in China In Oct’2014, […]
Galecto’s GB0139 Receives the US FDA’s and EMA’s Orphan Drug Designations for Idiopathic Pulmonary Fibrosis
Shots: The US FDA and EMA has received ODD to Galecto’s GB0139 for the treatment of IPF. GB0139 showed significant reduction of YKL-40 biomarker in […]
FDC Launches Two Variants of Favipiravir for COVID-19 in India
Shots: FDC has launched two variants of Favipiravir under the brand names PiFLU and Favenza to treat mild to moderate COVID-19 in India. The products […]
Takeda Collaborates with Engitix to Target Fibrotic Liver Diseases
Shots: Engitix to receive up front with additional payments based on the confirmation and functional validation of selected targets and is eligible to receive $500M […]
AbbVie and Harvard University Collaborate to Develop Novel Therapies Against Emergent Viral Diseases
Shots: AbbVie and Harvard University enter a $30M research alliance to study & develop novel therapies against emergent viral infections with an initial focus on […]
AbbVie Exercises its Option to License Morphosys’ αvβ6 Integrin Inhibitor Program for Fibrotic Disease
Shots: Morphic will receive a $20M as license fee and is eligible to receive milestones and royalties on sales of any commercialized therapy while AbbVie […]
Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020
SMi reports: Alan Franklin, CEO, ForwardVue Pharma will be presenting at the Ophthalmic Drugs conference The 4th Annual Ophthalmic Drugs Conference taking place on the […]
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan
Shots: Takeda and Blackstone sign an agreement to divest it consumer health care business unit for $2.3B. The transaction expected to be closed by Mar […]
AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases
Shots: The two companies will develop and launch precision medicine strategies for CV, renal, and metabolic diseases. The first stage in the collaboration will use […]
BioMarin Reports NDA Submission to the US FDA for Vosoritide to Treat Children with Achondroplasia
Shots: BioMarin has submitted an NDA to the US FDA for vosoritide to treat children with achondroplasia The company also reported that EMA has begun […]
Junshi and Impact to Establish Joint Venture for Senaparib (IMP4297) in China
Shots: The two companies will co-develop and conduct clinical trials for senaparib across multiple cancer indications in China. Junshi to invest $43.4M in cash, representing […]
Qualitative KOL Mapping
If you were trying to identify the most influential people within a large and active Facebook group, would you restrict yourself to analysing “number of […]
Court approves Otsuka’s bid to buy Proteus for $15M
A bankruptcy court in Delaware approved a stalking-horse bid from Otsuka to acquire Proteus Digital Health for $15 million. The company, which makes sensor that […]
Precision BioSciences Receives the US FDA’s Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphoblastic Leukemia
Shots: The US FDA has granted FT designation for PBCAR0191 to treat advanced B-ALL. FT designation facilitates the expedited development and review of a new […]
Some startups grapple with USPS delays in medication delivery
Some healthcare startups that offer at-home prescription deliveries and test kits have experienced delays with the USPS. They shared how they’re navigating the changes.
Roche’s Tecentriq + Bevacizumab Receive Health Canada’s Approval as 1L Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
Shots: The approval is based on P-III IMbrave150 study assessing Tecentriq (1200 mg) + bevacizumab (15 mg/kg, q3w, IV) vs sorafenib (400mg, bid) in 501 […]
The US FDA Rejects Gilead’s Filgotinib Due to Toxicity Issues
Shots: The US FDA has issued a complete response letter for the NDA of filgotinib to treat moderately to severely active RA. FDA has requested […]
Sanofi’s Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis
Shots: The Health Canada has approved a new indication as an add-on maintenance treatment with intranasal corticosteroids in patients with CRSwNP, inadequately controlled by systemic […]
Novo Nordisk Collaborates with Evotec to Develop Therapies Targeting Chronic Kidney Disease
Shots: Evotec to receive $179M/ product as upfront, research funding and milestones along with the royalties on sales of the therapies while Novo Nordisk will […]
I put together a blog highlighting 20 Pharma Key Opinion Leaders (KOL). Is this information helpful to the pharmaceutical industry?
Hi I hope everyone is doing well in these crazy times. Durning my down time i’ve been creating a blog on the top Key Opinion […]
Lilly and Innovent Report the Global Expansion of their Alliance for Tyvyt (sintilimab)
Shots: Innovent to receive $200M up front, $825M as development and commercial milestones along with royalties on net sales of the therapy. Both the companies […]
G1 Therapeutics Reports the US FDA Acceptance and Priority Review of NDA for Trilaciclib to Treat SCLC
Shots: The NDA submission is based on three clinical studies in which Trilaciclib was administered prior to chemotherapy treatment in patients with SCLC and has […]
PTC Reports the EMA’s Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA
Shots: The MAA submission is based on dose-finding Part 1 and confirmatory Part 2 of the FIREFISH and SUNFISH studies evaluating the efficacy and safety […]
AstraZeneca’s Imfinzi (durvalumab) Receives the US FDA’s Priority Review for Less Frequent Fixed-Dose Use in NSCLC and Bladder Cancer
Shots: The US FDA has accepted sBLA and granted PR to Imfinzi (1500mg) for a new 4wks. FD regimen to treat patients with unresectable Stage […]
Gilead Expands its Oncology Collaboration with Tango for ~$6.3B
Shots: Tango to receive $125M up front, $20M as equity investment, up to $410M/ program as an opt-in, extension, and milestones along with royalties on […]
Former KKR Vet Jim Momtazee Launches Healthcare Investment Firm, Patient Square Capital
Jim Momtazee, Managing Partner at Patient Square Capital What You Should Know: – Former KKR veteran Jim Momtazee announced the launch of Patient Square Capital, […]
BMS Signs an Exclusive Worldwide License Agreement with Dragonfly Therapeutics for DF6002
Shots: Dragonfly to receive $475M as up front and is eligible to receive development, regulatory and commercial milestones in addition to 24% royalties on global […]
Sanofi to Acquire Principia Biopharma for ~$3.68B
Shots: Sanofi to acquire Principia Biopharma in an all-stock transaction, at $100/share making total deal value ~$3.68B in cash. The transaction is expected to be […]
Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives
Swittons, a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs. The fully customizable […]
Know about drug monograph template and format
A drug, when launched, goes through a series of medical tests by different medical associations. The tests’ findings are compiled on a report, and the […]
Direct-to-consumer pharmacy company Thirty Madison raises $47M
Thirty Madison, which owns direct-to-consumer pharmacy brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led […]
Solasia Signs a License Agreement with Isofol to Develop and Commercialize Arfolitixorin for mCRC in Japan
Shots: Isofol to receive $100M as up front, development, regulatory and commercial milestones, and clinical development cost and is eligible to receive royalties on sales […]
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advanced Solid Tumors
Shots: The multiple expansion cohort will assess the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 in patients with advanced solid tumors […]
Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India
Shots: The company has launched Remdec at a price of $37.41 (Rs. 2800) for a 100mg lyophilized injection. The generic version is the most economical […]
Number of cures needed to.eliminate diseases
have been trying to find a reliable source on number of cures needed to eliminate diseases from this world. Do you have any info that […]
Montelucast / singulair – dangerous?
Hey there, my MCAS specialist prescribed montelucast to me. I’ve read it can worsen depression and suicidal ideation /- behavior. I can not assess how […]
Top 5 pain points in Pharma sales and marketing
For those of you working in Pharma today. What are the top 5 pain points you would pay to have fixed when marketing and selling […]
Famotidin – contraindicated?
H2-Blocker Famotidin (Propylenglycol.) and gastrointestinal symptoms My doctor gave me a bunch of new medication today. Including Famotidin. I‘ve just done some research and read […]
Gilead Reports NDA Submission to the US FDA for Veklury (Remdesivir) to Treat COVID-19
Shots: The NDA filing is based on P-III studies evaluating Veklury vs PBO, conducted by NIAID. The studies demonstrated that Veklury led to faster time […]
Tips to select PCD Pharma Franchise
Thinking about owning a franchise company or starting off your career as a marketing professional for a pharmaceuticals producer, you are moving in the right […]
Roche Report Mixed Results of Etrolizumab in P-III Studies for Patients with Moderately to Severely Active Ulcerative Colitis
Shots: In the HIBISCUS I induction study, in patients without prior anti-TNF treatment, etrolizumab met its 1EPs while in HIBISCUS II study in the same […]
Why MedCity News should be your go-to advertising partner
MedCity News has the most engaged healthcare business audience in the industry. We can collaborate with you to develop customized content or provide a platform for […]
Roche’s Evrysdi (risdiplam) Receives the US FDA’s Approval for SMA in Adults and Children
Shots: The US FDA has approved Evrysdi to treat SMA in adults and children ≥ 2mos. The approval is based on two clinical studies designed […]
Bausch Health to Spin off its Eye Health Business
Shots: Bausch Health spin-off its leading eye health business into an independent publicly-traded company under the name Bausch + Lomb. The spinoff is expected to […]
Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson’s Disease Worth ~$2.125B
Shots: Denali to receive $560M up front, $465M as equity investment at a price of $34.94/ share, representing 11.2% of Denali’s Pro-forma outstanding stock along […]
UCB’s Cimzia (certolizumab pegol) Receives the EMA’s Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum
Shots: The P-IIIb C-OPTIMISE study assessing Cimzia (200mg, q2w with a loading dose of 400mg @ 0, 2 & 4wks.) vs PBO during 48wks. open-label […]
Lundbeck Halts P-II Study of Lu AF11167 in Patients with Negative Symptoms of Schizophrenia
Shots: The company discontinues P-II proof POC study of Lu AF11167 in patients with schizophrenia, who are experiencing persistent negative symptoms (NCT03793712). The P-II study […]
Playing an Active Role in Treatment Yields More Confidence in Patients
When aiming to reach the people who will benefit most from a given medication or therapy, patients who play an active role in treatment decisions […]
How do pharma drugs actually end up on pharmacy shelves? And why the difference between countries?
I live in Europe and I’m struggling to get drugs that a family member needs in my country. When I say struggling I mean I […]
Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India
Shots: Lupin has launched favipiravir in India under the brand name ‘Covihalt’ for the treatment of mild to moderate COVID-19 Covihalt will be available as […]
Pre-filled Syringes San Francisco will now take place as a Virtual Conference
SMi Reports: Due to the ongoing challenges surrounding COVID-19 and large public gatherings, September’s Pre-filled Syringes San Francisco conference will now run as a virtual […]
Ophthalmic Drug Delivery Development – Trials and Tribulations workshop
SMi reports: Brian Levy, CEO, Ocunexus Therapeutics will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic Drugs […]
LEO Pharma Receives the US FDA’s Fast Track Designation for Delgocitinib Cream to Treat Moderate-to-Severe Chronic Hand Eczema
Shots: The US FDA has granted FT designation to LEO’s delgocitinib cream as the potential treatment for adults with moderate-to-severe CHE. There are currently no […]
AstraZeneca Signs a License Agreement with Redx Pharma for RXC006 to Treat Idiopathic Pulmonary Fibrosis
Shots: Redx to receive $17M in early payment by the time of successful commencement of a P-I study, $360M as development, a regulatory and commercial […]
The Elusive KOL Pyramid
The traditional KOL pyramid – you know the one, with the most influential global experts at the top and the front-line national HCPs lower down […]
Merck and Hanmi Collaborate to Develop Efinopegdutide for NASH
Shots: Hanmi to receive $10M up front, $860M as development, regulatory approval, and commercialization of efinopegdutide along with royalties on sales of the approved product […]
Novartis Reports Results of Kymriah (tisagenlecleucel) in P-II ELARA Study for Follicular Lymphoma
Shots: The P-II ELARA study involves assessing the efficacy and safety of Kymriah in adult patients with r/r FL across 12 countries in 30 sites […]
RedHill Replaces its Co-Commercialization Agreement with Daiichi Sankyo for Movantik (naloxegol)
Shots: The new agreement involves, Daiichi to get royalties on sales of Movantik plus payments each year starting from 2021 to 2023. RedHill to take […]
New speaker session with Kiniksa Pharmaceuticals at Pre-filled Syringes East Coast 2020
SMi Reports: new speaker session with Paul Roussel, Senior Director, Combination Products, at the Pre-filled Syringes East Coast 2020 conference I am pleased to inform […]
Report: GoodRx files for IPO
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The […]
MedCity News will help you reach clients and raise awareness during Covid-19
With more readers and greater engagement in our content than ever, we have many products that can help you reach your customer base through our […]
Managing and Tracking Cross-functional KOL Collaborations
It’s often the case that different functions within your organisation are working with the same KOLs – whether it’s across indications, franchise, or even R&D. […]
Roche’s Rozlytrek Receives EC’s Conditional Marketing Authorization for NTRK Fusion-Positive Solid Tumors and ROS1-Positive Advanced NSCLC
Shots: The approval is based on integrated analysis including data from 74 people with LA/ m-NTRK fusion-positive solid tumors (14 tumor types) & 161 people […]
ATORVASTATIN 10 MG – AN EFFECTIVE MEDICINE TO CURE CHOLESTEROL
A Hale and hearty lifestyle is a good initiative and can defense against high cholesterol. As some people have a genetic predisposition to high blood […]
Takeda’s Pevonedistat Receives the US FDA’s Breakthrough Therapy Designation to Treat Patients with Higher-Risk Myelodysplastic Syndrome
Shots: The BT designation is based on the final analysis of the Pevonedistat-2001 P-II study assessing pevonedistat + azacitidine vs azacitidine as monothx. in patients […]
PBM Startup Capital Rx Starts Prescription Drug Pricing Shake-Up with Walmart Partnership
By JESSICA DaMASSA, WTF HEALTH A startup PBM? Partnered up with Walmart to bring “everyday low prices” to prescription drug pricing? Is this too good […]
Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets
Shots: Sangamo to receive $75M upfront within 30 days, $720M milestone payments including up to $420M in development milestones and up to $300M in commercial […]
Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes
Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients […]
AstraZeneca’s Tagrisso (osimertinib) Receives the US FDA’s BT Designation for the Adjuvant Treatment of Patients with Stage IB-IIIA EGFR-Mutated Lung Cancer
Shots: The BT designation is based on P-III ADAURA trial which involves assessing Tagrisso (80 mg) vs PBO in 682 patients with Stage IB, II, […]
Merck’s MK-6482 Receives the US FDA’s Breakthrough Therapy Designation to Treat Patients With Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma
Shots: The designation is based on P-II study evaluating MK-6482 in patients with VHL-associated RCC with nonmetastatic RCC tumors >3cms in size, unless immediate surgery […]
AbbVie Report Results of Rinvoq (upadacitinib) in a P-III AD Up Study for Patients with Atopic Dermatitis
Shots: The P-III AD Up study involves assessing Rinvoq (15/30mg) + TCS vs PBO + TCS in patients (aged≥12) with the mod. to sev. AD […]
Ciox Health Acquires Biomedical NLP Company Medal
What You Should Know: – Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company. – The acquisition will lead Ciox to […]
AstraZeneca Report Results of Farxiga in P-III DAPA-CKD Study for Patients with Chronic Kidney Disease
Shots: The P-III DAPA-CKD involve assessing of Farxiga ((dapagliflozin, 10mg, qd) + SOC vs PBO in 4,304 patients with CKD Stages 2–4 and elevated urinary […]
Eli Lilly Amends its 2013 Agreement with Chi-Med to Commercialize Elunate (fruquintinib) in China
Shots: Chi-Med to receive 70%-80% of Elunate sales in the form of royalties, manufacturing costs and service payments with no upfront regarding this amendment. Lilly […]
Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India
Shots: Jenburkt became the second company to launch Favivent (favipiravir) to treat mild to moderate COVID-19 symptoms at a price of Rs. 39/tablet Cipla receives […]
Gilead and Galapagos’ Jyseleca (filgotinib) Receive the CHMP’s Positive Opinion for Moderate to Severe Rheumatoid Arthritis
Shots: Then CHMP’s positive opinion is based on P-III FINCH and P-II DARWIN programs that included 4,544 RA patient-years of experience with filgotinib. All three […]
Zydus to Initiate Clinical Study of Desidustat in Patients with Chemotherapy-Induced Anemia (CIA)
Shots: Zydus has received the US FDA’s approval to initiate clinical trials of Desidustat in CIA. The company has initiated two P-III studies of desidustat […]
AstraZeneca’s Breztri Aerosphere Receives the US FDA’s Approval for the Maintenance Treatment of COPD
Shots: The approval is based on P-III ETHOS study assessing of Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) vs dual therapies [Bevespi Aerosphere (glycopyrronium/formoterol fumarate) and PT009 (budesonide/formoterol […]
BioMarin Reports the Submission of MAA to EMA for Vosoritide to Treat Children with Achondroplasia
Shots: The MAA is based on P-III study assessing the efficacy and safety of vosoritide, further supported by the long-term safety and efficacy from the […]
Men’s wellness startup Hims rolls out telepsychiatry
Men’s health startup Hims is further expanding into mental health by offering psychiatric consults online. […]
Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndrome
Shots: Ovid will collaborate with UConn’s Stormy J. Chamberlain and secures exclusive access to identified genetic sequences for shRNA-based therapy. Ovid plans to leverage its […]
Glenmark Report Results of FabiFlu (favipiravir) in P-III Clinical Study for Patients with Mild to Moderate COVID-19
Shots: The P-III study assessing the efficacy and safety of Favipiravir + SSC vs SCC in 150 mild to moderate patients, randomized within a 48hour […]
Prescient Announces Recent Appointments to the Senior Advisory Team
Prescient hires two new senior members to support its fast-growing Advisory business LONDON, July 20, 2020—Prescient, a biopharma product and portfolio strategy firm, announces the […]
AbbVie Reports Results of Rinvoq (upadacitinib) as Monotherapy in a P-III Measure Up 2 Study for Atopic Dermatitis
Shots: The P-III Measure Up 2 study involves assessing of Rinvoq (15/30mg) vs PBO in adults and adolescents aged 12-18yrs. or older with mod. to […]
Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India
Shots: Mylan launches Desrem (remdesivir) addressing the unmet needs amid COVID-19. The drug is approved for the treatment of suspected or laboratory-confirmed incidences of COVID-19 […]
Royalty Pharma Acquires PTC’s Royalty Interest in Risdiplam for $650M
Shots: PTC Therapeutics to receive $650M as upfront in cash in exchange for ~43% of the risdiplam royalties, up to a specified amount while PTC […]
Need help identifying resources on excipients for biopharmaceutical formulations
Dear all, Guest here. I am researching parenteral (injectable) formulations for bipharmaceuticals. Does anybody know of any databases of approved, marketed products and their formulations? […]
Know about scientific and regulatory consultants
Knowledge of the competition is another of the pillars of Regulatory consulting Services, knowing what your competitors are doing and what market niches are being […]
Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs
SMi reports: Dr. Thakur Raghu Raj Singh from Queen’s University Belfast will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the […]
Featured speakers for 2nd annual Wearable Injectors and Connected Devices Conference
SMi Reports: Featured Speakers listed for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. The global wearable devices market […]
Benefits of Biotech Consulting Services
An experienced professional pharma consulting service, such as Biotech Research Group, can be hired by companies with variety of their own staff. The consulting firm […]
Developing custom syringes for highly viscous formulations discussed at PFS San Francisco
SMi Reports: ‘Developing custom syringes for highly viscous formulations’ one of the many topics to be presented at the inaugural Pre-filled Syringes San Francisco Conference […]
Merck KGaA Takes an Early Option in its Existing Immuno-Oncology Collaboration with F-star
Shots: F-star to receive option exercise payment and will be eligible to get milestones and royalties on net sales of therapies resulting from the collaboration. […]
MSD Collaborates with Novocure to Evaluate Tumor Treating Fields Together with Keytruda (pembrolizumab) in Non-Small Cell Lung Cancer
Shots: The companies plan to conduct a P-II pilot study of tumor treating fields concomitant with Keytryda for 1L treatment of intrathoracic advanced/ metastatic PD-L1+ […]
AstraZeneca Report Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Shots: The P-III THALES study involves assessing of Brilinta (180mg as a loading dose followed by 90mg, bid) + aspirin vs aspirin as monothx. in […]
Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19
Shots: Novartis will offer a portfolio of 15 generic and OTC medicines addressing the need of low- and lower-middle-income countries to treat patients with COVID-19 […]
Digital pharmacy startup Medly raises $100M
Medly, a New York-based digital pharmacy startup that offers same-day prescription delivery, raised $100 million in a series B round.
INVESTIGATIONAL NEW DRUG APPLICATION (IND)/SPECIAL PROTOCOL ASSESSMENT (SPA)
First, PDG will help you determine if an IND is required. FDA Guidance notes that there are times when it may not be clear if […]
Treating Pharma Data as an Asset: moving from an application centric to an information-centric organization – presented by Dr. Martin Romacker, Roche
Pharma knows there is a need for clean, reusable, FAIR data to fuel effective machine learning-driven R&D – but driving effective information and knowledge management […]
Propeller gets green light to bundle its digital health tools with inhalers
Propeller Health and Novartis received the green light from European regulators to package their products together. The move is one step of many to make […]
Walmart confirms a new avatar — it’s also a health insurance agency
Walmart quietly launched a new health insurance business. The company, called Walmart Insurance, was filed with the Arkansas Secretary of State last month.
Anthem’s PBM buys pharmacy startup Zipdrug
Anthem’s newly formed PBM, IngenioRx, acquired pharmacy startup Zipdrug. The company facilitates in-home drug delivery and helps health plans track medication adherence.
Just a Little Prick (Part One)
[link] [comments]
Gilead’s $2,340 Price for Coronavirus Drug Remdesivir Draws Criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course […]
looking for easy.fun.intresting medical information? go ahead and follow us at
https://www.instagram.com/jood.ology/ submitted by /u/ibrahim_osama [link] [comments]
Research And Development | Bliss GVS Pharma Limited
submitted by /u/BlissGVS [link] [comments]
Infrastructure | Bliss GVS Pharma Limited
submitted by /u/BlissGVS [link] [comments]
About Us – Bliss GVS Pharma Limited
submitted by /u/BlissGVS [link] [comments]
Bliss GVS Pharma Limited – A Global Pharma Company
submitted by /u/BlissGVS [link] [comments]
Is anyone looking to import regulated pharma products small scale?
Looking to help out anyone wanting to import regulated products into Canada on a small scale. submitted by /u/QualityandCompliance [link] [comments]
What are some questions that occur in mind related to the pharma business?
submitted by /u/Venistro-Biotech [link] [comments]
an abandoned nuclear site seems like a safe place to manufacture drugs..
Came across this YouTube video on Jacobus Pharmaceuticals in Plainsboro, NJ. Beyond how bizarre the story is, there’s no website or contact info for Jacobus. […]
Which US pharma companies have big presence/HQs in China?
Looking for jobs in pharma and would like the opportunity to extern overseas at some point. submitted by /u/sandstone5 [link] [comments]
Promising pharma/biotech companies that focus on CNS/neurology?
Graduated w/ bachelor’s in neuroscience, looking for jobs in pharma, would like to work at a company that focuses on the CNS. Doing my own […]
Anticholinergic H1 antihistamine – mast cell activation
Is it a good or a bad idea to give Dimetinden (Fenistil) to a person with mast cell disorder who experiences frequent anaphylaxis with strong […]
What are the drivers and opportunities for the cleanroom lighting market?
Factors such as need for controlled environment with extremely low levels of pollutants in manufacturing industries, Stringent regulations in healthcare and food processing industries to […]
A Systems Thinking Approach for Pharma
Systems thinking asks scientists to look at the bigger picture and take a more holistic approach to their work. Systems thinkers consider how their field […]
Interactions between methylphenidate and niacin supplements?
I’m taking methylphenidate and was going to try niacin supplements. Would there be any potentially dangerous interactions? submitted by /u/BetterMyself2020 [link] [comments]
In defense of big pharma :-) read it and quote it!
https://www.fastcompany.com/90504726/in-defense-of-big-pharma-the-innovation-engine-we-love-to-hate submitted by /u/moneywerm [link] [comments]
Want to start a business in the ePharmacy industry?
The growth of the Global ePharmacy market valued approximately USD 42.32 billion in 2019, and it is anticipated to grow USD 107.53 by 2024. Let […]
https://finance.yahoo.com/news/moleculin-announces-active-compound-wp1122-113000553.html?.tsrc=rss
Does anyone know if this is real, or has heard anything about it? submitted by /u/moneywerm [link] [comments]
Good Beginners Book on HTAs?
Hello, I’m based in UK and I just finished my masters in Pharmaceuticals but we didn’t really go over market access, pricing, reimbursement, and HTAs […]
What is Coronavirus ? Coronavirus Symptoms and Prevention
What is Coronavirus ?, Coronavirus Symptoms and Prevention Understanding the Novel Coronavirus (2019-nCoV) What is Coronavirus According to the World Health Organization[i], Coronaviruses (CoV) are […]
Have anti-vaxxers pivoted to blaming 5g?
submitted by /u/drugpatentwatch [link] [comments]
Sourcing investigational COVID-19 drugs
Are you trying to source investigational COVID-19 drugs? We’ve pulled out all the relevant supply-chain resources at https://www.drugpatentwatch.com/covid-19/ . Let me know what more we […]
Iron Sucrose Injection Manufacturer India | Systacare Remedies
Systacare Remedies is a reputed Iron Sucrose Injection Manufacturer in India {WOOFEV IV}. Woofer IV is a dark brown, non-transparent, aqueous solution that is used […]
The Best discount online pharmacy
The first online pharmacy (http://rxlegal-online.com) which offers the easiest way of placing order, the fastest shipping to any place on the globe and the cheapest […]
GenScript Signs an Agreement with Selecxine to Develop Therapies for Immuno-Oncology
Shots: GenScript will be responsible for all pre-clinical pharmacy research and IND filling in Selecxine’s project which is based on cytokine-antibody complexes The company provided […]
Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases
Shots: Fulcrum to receive $10M upfront, reimbursement for R&D costs, research, development and commercial milestone of up to $295M for first product commercialized and additional […]
Eli Lilly Opens its P-III LIBRETTO-531 Clinical Trial for LOXO-292 (selpercatinib) to Treat RET-Mutant Medullary Thyroid Cancer (MTC) Patients
Shots: The second P-III LIBRETTO-531 involves assessing of selpercatinib vs physician’s choice of cabozantinib or vandetanib in 400 patients in ratio (2:1) with advanced or […]
Eisai Reports Results of DAYVIGO (lemborexant) in P-III SUNRISE 1 Study in Patients with Insomnia Disorder
Shots: The P-III SUNRISE 1 (Study 304) study involves assessing of DAYVIGO (lemborexant, 5 or 10 mg) vs an active comparator or PBO in 1,006 […]
Clover Reports Dosing of SCB-808 (biosimilar, etanercept) in P-III Trial in China
Shots: The P-III study involves assessing of SCB-808 vs Enbrel in patients with AS (axSpA) via SC administration SCB-808 is being developed in the prefilled […]
Opportunities and Obstacles for Online Pharmacies in the UK
More and more businesses are transitioning to a digital platform, using the power of technology to improve the products and services offered and delivered to […]
This subreddit is now for text posts only to encourage discussion.
Due the a complete lack of discussion on most all of what is being posted here I am changing the sub to only allow text […]
